{"id":"W2151974389","doi":"10.1016/j.jaad.2013.08.058","title":"Comment on ‘A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis’","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Adalimumab; Sarcoidosis; Randomized controlled trial; Double blind; Cutaneous Sarcoidosis; Dermatology; Placebo; Surgery; Internal medicine; Alternative medicine; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01277401,0.001214153,0.003549508,0.001121382,0.00344905,0.003159138,0.003777467,0.06757,0.007174578],"category_scores_gemma":[0.04960547,0.001329815,0.003236374,0.001213163,0.0041519,0.00330251,0.001090995,0.03509051,0.008366496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006223126,"about_ca_system_score_gemma":0.004811437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007153171,"about_ca_topic_score_gemma":0.009445494,"domain_scores_codex":[0.9916859,0.003160826,0.001084967,0.001336457,0.001959459,0.000772315],"domain_scores_gemma":[0.9730172,0.01922137,0.002313045,0.0007259427,0.002920112,0.00180234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00178255,0.00009357343,0.0006363654,0.0002331673,0.0001472685,0.0007739151,0.0001057596,0.00009722407,0.0003525637,0.001515902,0.9860138,0.00824787],"study_design_scores_gemma":[0.006907518,0.001203669,0.005406506,0.001287292,0.0007934144,0.001741378,0.0003579775,0.001636706,0.00203669,0.01145795,0.9668746,0.0002962303],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0009180911,0.001460772,0.000217075,0.9570535,0.03814626,0.00006194872,0.0003867723,0.0001170229,0.001638391],"genre_scores_gemma":[0.002630658,0.0003179851,0.0002772119,0.9682475,0.02612766,0.00008247721,0.00005185809,0.00002422364,0.002240417],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.06757,"threshold_uncertainty_score":0.06755626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05246746411254041,"score_gpt":0.3633157057440923,"score_spread":0.3108482416315519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}